Logo
N

NeuBase Therapeutics, Inc.

24 employees

NeuBase Therapeutics develops gene silencing therapies with its synthetic antisense oligonucleotides.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Myotonic Dystrophy
Biotechnology
Genetic Disease
Therapeutics
Gene Silencing
Antisense Oligonucleotide Therapies
CNS Disease
Rare Disease
Medical
gene editing
Huntington's Disease

Date founded

2018

FAQ